Kendra Young
Concepts (305)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lupus Erythematosus, Systemic | 10 | 2022 | 221 | 2.680 |
Why?
| Pulmonary Disease, Chronic Obstructive | 23 | 2024 | 928 | 2.530 |
Why?
| Tobacco Use Disorder | 4 | 2022 | 236 | 1.080 |
Why?
| Smoking | 13 | 2023 | 1392 | 1.070 |
Why?
| Mexican Americans | 2 | 2019 | 101 | 0.980 |
Why?
| Receptors, Complement 3d | 10 | 2010 | 130 | 0.970 |
Why?
| Genetic Predisposition to Disease | 13 | 2023 | 2108 | 0.960 |
Why?
| Autoantibodies | 8 | 2022 | 1354 | 0.950 |
Why?
| Smokers | 9 | 2023 | 129 | 0.930 |
Why?
| Vitamin D | 5 | 2022 | 340 | 0.920 |
Why?
| Bronchiectasis | 5 | 2023 | 107 | 0.920 |
Why?
| Non-alcoholic Fatty Liver Disease | 3 | 2023 | 246 | 0.840 |
Why?
| Herpesvirus 4, Human | 4 | 2019 | 125 | 0.800 |
Why?
| Diabetes Mellitus, Type 2 | 6 | 2023 | 2098 | 0.800 |
Why?
| Vitamin D Deficiency | 2 | 2016 | 158 | 0.780 |
Why?
| Genome-Wide Association Study | 14 | 2023 | 1203 | 0.760 |
Why?
| Blood Pressure Monitoring, Ambulatory | 1 | 2020 | 61 | 0.700 |
Why?
| Family | 2 | 2014 | 591 | 0.680 |
Why?
| Alanine Transaminase | 2 | 2020 | 140 | 0.680 |
Why?
| Lipase | 1 | 2019 | 57 | 0.650 |
Why?
| Aspartate Aminotransferases | 1 | 2019 | 86 | 0.650 |
Why?
| Inflammation Mediators | 2 | 2019 | 476 | 0.640 |
Why?
| Polymorphism, Single Nucleotide | 11 | 2023 | 1901 | 0.620 |
Why?
| Virus Attachment | 2 | 2008 | 11 | 0.620 |
Why?
| Smoking Cessation | 1 | 2022 | 376 | 0.610 |
Why?
| Cholesterol, HDL | 1 | 2018 | 184 | 0.600 |
Why?
| Membrane Proteins | 2 | 2020 | 1019 | 0.550 |
Why?
| Vitamin D3 24-Hydroxylase | 1 | 2016 | 14 | 0.540 |
Why?
| Triglycerides | 1 | 2018 | 471 | 0.540 |
Why?
| Tomography, X-Ray Computed | 11 | 2023 | 2341 | 0.540 |
Why?
| Coronary Artery Disease | 3 | 2023 | 608 | 0.530 |
Why?
| Adiposity | 2 | 2012 | 466 | 0.520 |
Why?
| Arthritis, Rheumatoid | 4 | 2022 | 1002 | 0.520 |
Why?
| Metabolic Syndrome | 1 | 2018 | 324 | 0.500 |
Why?
| Middle Aged | 28 | 2023 | 26826 | 0.490 |
Why?
| Forced Expiratory Volume | 11 | 2024 | 476 | 0.480 |
Why?
| Insulin-Secreting Cells | 1 | 2018 | 318 | 0.480 |
Why?
| Atherosclerosis | 3 | 2023 | 342 | 0.470 |
Why?
| Humans | 68 | 2024 | 115038 | 0.470 |
Why?
| Pulmonary Emphysema | 3 | 2023 | 280 | 0.450 |
Why?
| Insulin Resistance | 2 | 2018 | 1077 | 0.440 |
Why?
| Spirometry | 9 | 2024 | 225 | 0.440 |
Why?
| Sleep | 1 | 2018 | 631 | 0.420 |
Why?
| Joints | 1 | 2013 | 84 | 0.420 |
Why?
| Viral Matrix Proteins | 4 | 2008 | 24 | 0.420 |
Why?
| Hypertension | 1 | 2020 | 1058 | 0.410 |
Why?
| Male | 32 | 2023 | 55729 | 0.400 |
Why?
| Female | 34 | 2023 | 59610 | 0.400 |
Why?
| Complement C3d | 7 | 2010 | 60 | 0.380 |
Why?
| Risk Factors | 18 | 2023 | 8642 | 0.380 |
Why?
| Emphysema | 2 | 2023 | 110 | 0.370 |
Why?
| Genetic Loci | 4 | 2022 | 264 | 0.350 |
Why?
| Autoimmunity | 3 | 2022 | 818 | 0.350 |
Why?
| Adult | 17 | 2023 | 30654 | 0.340 |
Why?
| Follow-Up Studies | 8 | 2022 | 4420 | 0.330 |
Why?
| Diabetic Angiopathies | 1 | 2010 | 244 | 0.310 |
Why?
| Calcinosis | 1 | 2010 | 242 | 0.310 |
Why?
| Viral Envelope Proteins | 1 | 2007 | 74 | 0.280 |
Why?
| HLA-DR4 Antigen | 1 | 2007 | 76 | 0.280 |
Why?
| Prospective Studies | 9 | 2023 | 6232 | 0.270 |
Why?
| Rheumatoid Factor | 1 | 2007 | 157 | 0.260 |
Why?
| Glycoproteins | 1 | 2007 | 305 | 0.260 |
Why?
| Population Surveillance | 2 | 2021 | 392 | 0.250 |
Why?
| Tobacco Use | 2 | 2023 | 60 | 0.250 |
Why?
| Genotype | 6 | 2022 | 1780 | 0.250 |
Why?
| Alcohol Drinking | 2 | 2022 | 655 | 0.250 |
Why?
| Multifactorial Inheritance | 2 | 2023 | 125 | 0.250 |
Why?
| Genetic Markers | 2 | 2019 | 323 | 0.240 |
Why?
| Artificial Intelligence | 2 | 2023 | 145 | 0.240 |
Why?
| Cohort Studies | 7 | 2023 | 4904 | 0.240 |
Why?
| Acyltransferases | 2 | 2023 | 46 | 0.230 |
Why?
| Liver | 3 | 2023 | 1681 | 0.230 |
Why?
| Vitamin D-Binding Protein | 2 | 2016 | 13 | 0.230 |
Why?
| Autoimmune Diseases | 1 | 2007 | 394 | 0.220 |
Why?
| Receptors, Calcitriol | 2 | 2016 | 53 | 0.220 |
Why?
| Plaque, Atherosclerotic | 1 | 2023 | 44 | 0.220 |
Why?
| Aged | 13 | 2022 | 19119 | 0.220 |
Why?
| Drug Repositioning | 1 | 2023 | 13 | 0.220 |
Why?
| Phenotype | 7 | 2022 | 2815 | 0.210 |
Why?
| Risk Assessment | 5 | 2019 | 2976 | 0.210 |
Why?
| Tomography, Emission-Computed | 1 | 2022 | 58 | 0.210 |
Why?
| Peptides, Cyclic | 2 | 2015 | 254 | 0.210 |
Why?
| Population Health | 1 | 2023 | 42 | 0.210 |
Why?
| Liver Cirrhosis | 2 | 2023 | 235 | 0.210 |
Why?
| Hyperlipidemias | 1 | 2023 | 122 | 0.200 |
Why?
| Longitudinal Studies | 5 | 2023 | 2389 | 0.200 |
Why?
| Internationality | 1 | 2022 | 144 | 0.200 |
Why?
| Airway Obstruction | 1 | 2024 | 168 | 0.190 |
Why?
| Symptom Flare Up | 1 | 2021 | 38 | 0.190 |
Why?
| Disease Progression | 4 | 2023 | 2389 | 0.190 |
Why?
| Lung | 9 | 2023 | 3595 | 0.190 |
Why?
| Transcriptome | 2 | 2023 | 725 | 0.180 |
Why?
| Prevalence | 6 | 2023 | 2255 | 0.180 |
Why?
| Amino Acid Substitution | 4 | 2010 | 262 | 0.180 |
Why?
| Muscular Atrophy | 1 | 2021 | 78 | 0.180 |
Why?
| Mutagenesis, Site-Directed | 4 | 2010 | 345 | 0.180 |
Why?
| Respiratory Function Tests | 2 | 2019 | 523 | 0.180 |
Why?
| Genetic Variation | 2 | 2022 | 876 | 0.180 |
Why?
| Diabetes Mellitus, Type 1 | 2 | 2020 | 3245 | 0.180 |
Why?
| China | 1 | 2020 | 163 | 0.170 |
Why?
| Linear Models | 2 | 2019 | 776 | 0.170 |
Why?
| Alleles | 3 | 2019 | 792 | 0.170 |
Why?
| Blood Pressure Determination | 1 | 2020 | 122 | 0.170 |
Why?
| Quantitative Trait, Heritable | 1 | 2020 | 117 | 0.170 |
Why?
| Pulmonary Heart Disease | 1 | 2019 | 6 | 0.170 |
Why?
| Molecular Epidemiology | 1 | 2019 | 63 | 0.170 |
Why?
| gamma-Glutamyltransferase | 1 | 2019 | 42 | 0.170 |
Why?
| Nuclear Family | 1 | 2019 | 49 | 0.160 |
Why?
| Binding Sites | 5 | 2010 | 1173 | 0.160 |
Why?
| Protein Binding | 7 | 2010 | 1898 | 0.160 |
Why?
| Hepatitis C | 2 | 2011 | 226 | 0.160 |
Why?
| Antigens, Viral | 1 | 2019 | 176 | 0.160 |
Why?
| Heart Ventricles | 2 | 2020 | 714 | 0.150 |
Why?
| Blood Pressure | 2 | 2023 | 1539 | 0.150 |
Why?
| Herpesviridae Infections | 1 | 2019 | 138 | 0.150 |
Why?
| Vascular Remodeling | 1 | 2019 | 153 | 0.150 |
Why?
| Vital Capacity | 3 | 2023 | 257 | 0.150 |
Why?
| United States | 5 | 2020 | 12224 | 0.150 |
Why?
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2017 | 26 | 0.150 |
Why?
| Severity of Illness Index | 3 | 2021 | 2551 | 0.150 |
Why?
| Pulmonary Artery | 2 | 2022 | 1028 | 0.150 |
Why?
| Case-Control Studies | 4 | 2019 | 3015 | 0.140 |
Why?
| Prognosis | 3 | 2021 | 3334 | 0.140 |
Why?
| Lung Diseases | 1 | 2023 | 703 | 0.140 |
Why?
| Lipids | 1 | 2020 | 586 | 0.140 |
Why?
| Coronary Vessels | 1 | 2018 | 230 | 0.140 |
Why?
| Protein Structure, Tertiary | 3 | 2008 | 798 | 0.140 |
Why?
| Body Mass Index | 3 | 2021 | 1967 | 0.140 |
Why?
| Crystallography, X-Ray | 6 | 2010 | 405 | 0.140 |
Why?
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2016 | 16 | 0.140 |
Why?
| Fatigue | 1 | 2018 | 295 | 0.140 |
Why?
| Machine Learning | 1 | 2019 | 318 | 0.130 |
Why?
| Complement C3b | 3 | 2007 | 30 | 0.130 |
Why?
| Mutation, Missense | 2 | 2008 | 296 | 0.130 |
Why?
| Medical Staff, Hospital | 1 | 2016 | 74 | 0.130 |
Why?
| Antibodies, Viral | 1 | 2019 | 522 | 0.130 |
Why?
| Gene Frequency | 3 | 2022 | 483 | 0.120 |
Why?
| Abdominal Fat | 2 | 2017 | 43 | 0.120 |
Why?
| Fatty Acids, Omega-3 | 1 | 2015 | 124 | 0.120 |
Why?
| Antibodies, Antinuclear | 1 | 2014 | 60 | 0.110 |
Why?
| Multivariate Analysis | 3 | 2019 | 1435 | 0.110 |
Why?
| Enzyme-Linked Immunosorbent Assay | 4 | 2019 | 797 | 0.110 |
Why?
| Europe | 3 | 2022 | 336 | 0.110 |
Why?
| Hyperglycemia | 1 | 2016 | 293 | 0.110 |
Why?
| Fluorescent Antibody Technique | 1 | 2014 | 396 | 0.110 |
Why?
| Cross-Sectional Studies | 4 | 2024 | 4411 | 0.110 |
Why?
| Calcium | 1 | 2018 | 1104 | 0.110 |
Why?
| Models, Molecular | 6 | 2008 | 1379 | 0.100 |
Why?
| Recombinant Proteins | 5 | 2007 | 1237 | 0.100 |
Why?
| Sample Size | 2 | 2022 | 112 | 0.100 |
Why?
| Family Health | 1 | 2013 | 194 | 0.100 |
Why?
| Peptide Fragments | 3 | 2007 | 668 | 0.100 |
Why?
| Mutant Proteins | 2 | 2010 | 95 | 0.100 |
Why?
| Patient Care Team | 1 | 2016 | 515 | 0.100 |
Why?
| Dyspnea | 2 | 2024 | 218 | 0.100 |
Why?
| Cardiovascular Diseases | 1 | 2023 | 1729 | 0.100 |
Why?
| Proportional Hazards Models | 3 | 2019 | 1080 | 0.100 |
Why?
| Antibodies, Monoclonal | 4 | 2007 | 1268 | 0.100 |
Why?
| Hypertension, Pulmonary | 1 | 2022 | 1736 | 0.100 |
Why?
| Texas | 1 | 2012 | 187 | 0.100 |
Why?
| Registries | 1 | 2019 | 1763 | 0.090 |
Why?
| Predictive Value of Tests | 2 | 2018 | 1812 | 0.090 |
Why?
| Protein Interaction Mapping | 2 | 2008 | 102 | 0.090 |
Why?
| Chi-Square Distribution | 1 | 2012 | 498 | 0.090 |
Why?
| K562 Cells | 2 | 2007 | 73 | 0.090 |
Why?
| Epidemics | 1 | 2011 | 69 | 0.090 |
Why?
| Quality of Life | 1 | 2021 | 2359 | 0.090 |
Why?
| Depression | 1 | 2018 | 1136 | 0.090 |
Why?
| Life Style | 1 | 2012 | 431 | 0.080 |
Why?
| Retrospective Studies | 3 | 2021 | 12547 | 0.080 |
Why?
| Intra-Abdominal Fat | 1 | 2009 | 83 | 0.080 |
Why?
| Sex Factors | 2 | 2020 | 1721 | 0.080 |
Why?
| Exercise Tolerance | 2 | 2020 | 213 | 0.080 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2008 | 132 | 0.070 |
Why?
| Regression Analysis | 2 | 2022 | 948 | 0.070 |
Why?
| Insulin | 1 | 2017 | 2082 | 0.070 |
Why?
| Point Mutation | 1 | 2008 | 217 | 0.070 |
Why?
| Meta-Analysis as Topic | 2 | 2020 | 161 | 0.070 |
Why?
| Hospitalization | 1 | 2016 | 1754 | 0.070 |
Why?
| Surveys and Questionnaires | 2 | 2022 | 4631 | 0.070 |
Why?
| Polymorphism, Genetic | 1 | 2010 | 617 | 0.070 |
Why?
| Bottle Feeding | 1 | 2007 | 20 | 0.070 |
Why?
| Histocompatibility Testing | 1 | 2007 | 116 | 0.070 |
Why?
| Bronchodilator Agents | 2 | 2021 | 243 | 0.070 |
Why?
| Health Behavior | 1 | 2012 | 704 | 0.070 |
Why?
| Interferon-alpha | 1 | 2006 | 186 | 0.060 |
Why?
| Tobacco Smoke Pollution | 1 | 2007 | 217 | 0.060 |
Why?
| Phospholipases | 1 | 2023 | 13 | 0.060 |
Why?
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2023 | 22 | 0.060 |
Why?
| Carotid Intima-Media Thickness | 1 | 2023 | 65 | 0.060 |
Why?
| Biomarkers | 1 | 2013 | 3419 | 0.050 |
Why?
| Pandemics | 1 | 2011 | 1321 | 0.050 |
Why?
| Multimorbidity | 1 | 2023 | 33 | 0.050 |
Why?
| Aged, 80 and over | 3 | 2019 | 6357 | 0.050 |
Why?
| Nutrition Surveys | 1 | 2024 | 224 | 0.050 |
Why?
| B-Lymphocytes | 1 | 2007 | 772 | 0.050 |
Why?
| Colorado | 1 | 2012 | 4089 | 0.050 |
Why?
| Whole Genome Sequencing | 1 | 2022 | 96 | 0.050 |
Why?
| Pectoralis Muscles | 1 | 2021 | 13 | 0.050 |
Why?
| Biology | 1 | 2023 | 78 | 0.050 |
Why?
| Logistic Models | 1 | 2007 | 1839 | 0.050 |
Why?
| Reference Values | 1 | 2023 | 748 | 0.050 |
Why?
| Cell Line, Tumor | 1 | 2008 | 2715 | 0.050 |
Why?
| Epitope Mapping | 1 | 2001 | 51 | 0.050 |
Why?
| Bronchi | 1 | 2022 | 243 | 0.050 |
Why?
| Vitamins | 1 | 2022 | 151 | 0.050 |
Why?
| Ligands | 4 | 2006 | 565 | 0.050 |
Why?
| Adrenergic beta-2 Receptor Agonists | 1 | 2021 | 32 | 0.050 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2023 | 386 | 0.050 |
Why?
| Inheritance Patterns | 1 | 2020 | 45 | 0.050 |
Why?
| Molecular Sequence Annotation | 1 | 2020 | 81 | 0.040 |
Why?
| Interleukin-10 | 1 | 2022 | 297 | 0.040 |
Why?
| Linkage Disequilibrium | 1 | 2020 | 245 | 0.040 |
Why?
| Age Factors | 1 | 2007 | 2894 | 0.040 |
Why?
| Transforming Growth Factor beta | 1 | 2022 | 448 | 0.040 |
Why?
| rab4 GTP-Binding Proteins | 1 | 2019 | 8 | 0.040 |
Why?
| Cytochrome P-450 CYP2B6 | 1 | 2019 | 9 | 0.040 |
Why?
| Drug Discovery | 1 | 2020 | 124 | 0.040 |
Why?
| Hepacivirus | 2 | 2011 | 233 | 0.040 |
Why?
| Cytochrome P450 Family 2 | 1 | 2019 | 11 | 0.040 |
Why?
| Walk Test | 1 | 2019 | 52 | 0.040 |
Why?
| Administration, Inhalation | 1 | 2021 | 641 | 0.040 |
Why?
| Surface Plasmon Resonance | 3 | 2006 | 81 | 0.040 |
Why?
| Aryl Hydrocarbon Hydroxylases | 1 | 2019 | 41 | 0.040 |
Why?
| Genomics | 1 | 2023 | 641 | 0.040 |
Why?
| Binding, Competitive | 3 | 2006 | 195 | 0.040 |
Why?
| Organ Size | 1 | 2019 | 444 | 0.040 |
Why?
| Organ Specificity | 1 | 2019 | 270 | 0.040 |
Why?
| Cluster Analysis | 1 | 2019 | 458 | 0.040 |
Why?
| Self Report | 1 | 2022 | 698 | 0.040 |
Why?
| Drug Therapy, Combination | 1 | 2021 | 955 | 0.040 |
Why?
| Body Composition | 1 | 2021 | 586 | 0.040 |
Why?
| Tobacco Products | 1 | 2019 | 101 | 0.040 |
Why?
| Factor Analysis, Statistical | 1 | 2018 | 257 | 0.040 |
Why?
| Mortality | 1 | 2019 | 287 | 0.040 |
Why?
| Adrenal Cortex Hormones | 1 | 2021 | 499 | 0.040 |
Why?
| Incidence | 2 | 2015 | 2318 | 0.040 |
Why?
| Chronic Disease | 1 | 2023 | 1591 | 0.040 |
Why?
| Diagnostic Imaging | 1 | 2019 | 290 | 0.040 |
Why?
| Environment | 1 | 2019 | 335 | 0.040 |
Why?
| Cause of Death | 1 | 2018 | 364 | 0.030 |
Why?
| Kaplan-Meier Estimate | 1 | 2018 | 814 | 0.030 |
Why?
| Risk | 1 | 2019 | 815 | 0.030 |
Why?
| Glucose Tolerance Test | 1 | 2017 | 344 | 0.030 |
Why?
| Chromosomes, Human, Pair 4 | 1 | 2015 | 27 | 0.030 |
Why?
| Chromosomes, Human, Pair 15 | 1 | 2015 | 53 | 0.030 |
Why?
| Quantitative Trait Loci | 1 | 2017 | 309 | 0.030 |
Why?
| Amino Acid Sequence | 3 | 2006 | 1990 | 0.030 |
Why?
| Receptors, IgE | 2 | 2006 | 40 | 0.030 |
Why?
| Molecular Sequence Data | 3 | 2006 | 2796 | 0.030 |
Why?
| Genome, Human | 1 | 2015 | 351 | 0.030 |
Why?
| Mutagenesis | 2 | 2006 | 170 | 0.030 |
Why?
| Repetitive Sequences, Amino Acid | 2 | 2005 | 16 | 0.030 |
Why?
| Child, Preschool | 1 | 2007 | 9093 | 0.030 |
Why?
| Solutions | 2 | 2005 | 148 | 0.030 |
Why?
| Inflammation | 1 | 2022 | 2485 | 0.020 |
Why?
| Egypt | 1 | 2011 | 10 | 0.020 |
Why?
| Israel | 1 | 2011 | 37 | 0.020 |
Why?
| Asia | 1 | 2011 | 53 | 0.020 |
Why?
| Consensus Sequence | 2 | 2001 | 70 | 0.020 |
Why?
| Protein Conformation | 2 | 2006 | 811 | 0.020 |
Why?
| Time Factors | 2 | 2011 | 6141 | 0.020 |
Why?
| Australia | 1 | 2011 | 206 | 0.020 |
Why?
| Canada | 1 | 2011 | 322 | 0.020 |
Why?
| Molecular Dynamics Simulation | 1 | 2010 | 201 | 0.020 |
Why?
| Infant | 1 | 2021 | 7945 | 0.020 |
Why?
| Child | 1 | 2007 | 18407 | 0.020 |
Why?
| Spodoptera | 1 | 2006 | 37 | 0.020 |
Why?
| Myxovirus Resistance Proteins | 1 | 2006 | 8 | 0.020 |
Why?
| Dose-Response Relationship, Immunologic | 1 | 2006 | 76 | 0.020 |
Why?
| HSP40 Heat-Shock Proteins | 1 | 2006 | 21 | 0.020 |
Why?
| Glycosylation | 1 | 2006 | 131 | 0.020 |
Why?
| Polysaccharides | 1 | 2006 | 78 | 0.020 |
Why?
| GTP-Binding Proteins | 1 | 2006 | 141 | 0.020 |
Why?
| Sodium Chloride | 1 | 2006 | 136 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 1 | 2006 | 512 | 0.020 |
Why?
| Protein Structure, Quaternary | 1 | 2005 | 115 | 0.010 |
Why?
| Static Electricity | 1 | 2005 | 114 | 0.010 |
Why?
| Animals | 4 | 2010 | 31867 | 0.010 |
Why?
| Dimerization | 1 | 2005 | 176 | 0.010 |
Why?
| Membrane Glycoproteins | 1 | 2006 | 429 | 0.010 |
Why?
| Multiprotein Complexes | 1 | 2005 | 141 | 0.010 |
Why?
| Neutrons | 1 | 2002 | 5 | 0.010 |
Why?
| In Vitro Techniques | 1 | 2005 | 1036 | 0.010 |
Why?
| Scattering, Radiation | 1 | 2002 | 91 | 0.010 |
Why?
| Antigen-Antibody Complex | 1 | 2001 | 88 | 0.010 |
Why?
| Protein Sorting Signals | 1 | 2001 | 16 | 0.010 |
Why?
| Pichia | 1 | 2001 | 19 | 0.010 |
Why?
| Ultracentrifugation | 1 | 2001 | 48 | 0.010 |
Why?
| Hydrogen Bonding | 1 | 2001 | 143 | 0.010 |
Why?
| Cell Line | 1 | 2006 | 2645 | 0.010 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2001 | 138 | 0.010 |
Why?
| Sequence Alignment | 1 | 2001 | 325 | 0.010 |
Why?
| Protein Structure, Secondary | 1 | 2001 | 325 | 0.010 |
Why?
| Cloning, Molecular | 1 | 2001 | 524 | 0.010 |
Why?
| Structure-Activity Relationship | 1 | 2001 | 503 | 0.010 |
Why?
| Complement Activation | 1 | 2002 | 340 | 0.010 |
Why?
| Protein Folding | 1 | 2001 | 239 | 0.010 |
Why?
| Cells, Cultured | 1 | 2006 | 3896 | 0.010 |
Why?
| Computer Simulation | 1 | 2001 | 880 | 0.010 |
Why?
| HIV-1 | 1 | 2001 | 768 | 0.010 |
Why?
| Mice | 2 | 2002 | 14927 | 0.010 |
Why?
| Models, Biological | 1 | 2002 | 1636 | 0.010 |
Why?
| Mice, Knockout | 1 | 2001 | 2585 | 0.010 |
Why?
| T-Lymphocytes | 1 | 2001 | 1747 | 0.010 |
Why?
|
|
Young's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|